Farmacore Biotechnology Ltd

Belkins
Farmcore is a biotech company that develops and improves value in innovative biotechnological products during all stages, since conception of projects, to supply of active pharmaceutical ingredients (immunobiologicals) specially for the veterinary sector. As a Contract Manufacturing Organization, Farmcore owns technologically advanced Bioprocess Facilities allowing the production of a wide range of plasmid needs, permitting the lowest cost of production and highest product quality, especially in GMP regulated environments.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

MEDICAL

PFIZER AND BIONTECH BEGIN ROLLING SUBMISSION OF BIOLOGICS LICENSE APPLICATION FOR FDA APPROVAL OF COVID-19 VACCINE IN THE U.S

Pfizer, BioNTech | May 10, 2021

news image

Pfizer Inc. and BioNTech SE confirmed today the filing of a Biologics License Application (BLA) with the US Food and Drug Administration (FDA) for approval of their mRNA vaccine to prevent COVID-19 in people aged 16 and above. Companies will send data to help the BLA to the FDA on a rolling basis in the coming weeks, along with a proposal for Priority Review. If the BLA has been completed and duly approved for review by the FDA, the FDA will set a target date for a determination under the Prescr...

Read More

INDUSTRIAL IMPACT

OMEGA THERAPEUTICS ANNOUNCES STRATEGIC RESEARCH COLLABORATION WITH STANFORD UNIVERSITY SCHOOL OF MEDICINE

Omega Therapeutics, Inc | October 14, 2021

news image

Omega Therapeutics, Inc. ("Omega"), a development-stage biotechnology company pioneering the first systematic approach to use mRNA therapeutics as programmable epigenetic medicines by leveraging its OMEGA Epigenomic Programing™ platform, today announced a strategic research collaboration with researchers at the Stanford University School of Medicine to explore the therapeutic potential of Omega Epigenomic Controllers (OECs) to control ocular disease genes associated with inflamma...

Read More

RESEARCH

TURTLETREE LAUNCHES NEW RESEARCH AND DEVELOPMENT FACILITY IN GREATER SACRAMENTO

TurtleTree | October 04, 2021

news image

TurtleTree has officially opened its new R&D facility in California's state capital. Located in West Sacramento, this 24,000-square-foot building will house a world-class research hub showcasing the company's extensive array of innovations and cell-based technologies. Representing a milestone in TurtleTree's US-based expansion plans, the research facility will spur the development of precision fermentation technology currently used to produce valuable milk in...

Read More

BIOCLEAN INNOVATIONS AND REP-L® ANTIMICROBIALS PARTNERS TO LAUNCH A POWERFUL NON-TOXIC BIO-BASED ANTIMICROBIAL PRODUCT LINE

Bioclean Innovations | October 19, 2020

news image

Bioclean Innovations Inc, a Biotech startup focused on innovative antimicrobial solutions to combat disease outbreaks has partnered with rep-L® Antimicrobials, to launch a powerful but non-toxic bio-based antimicrobial product line. Our rep-L-based disinfectants are designed to create a new methodology for addressing the infection control challenges facing the education and long-term health care sectors today. The SARS-CoV-2 virus responsible for the COVID-19 pandemic is one of an increasing...

Read More
news image

MEDICAL

PFIZER AND BIONTECH BEGIN ROLLING SUBMISSION OF BIOLOGICS LICENSE APPLICATION FOR FDA APPROVAL OF COVID-19 VACCINE IN THE U.S

Pfizer, BioNTech | May 10, 2021

Pfizer Inc. and BioNTech SE confirmed today the filing of a Biologics License Application (BLA) with the US Food and Drug Administration (FDA) for approval of their mRNA vaccine to prevent COVID-19 in people aged 16 and above. Companies will send data to help the BLA to the FDA on a rolling basis in the coming weeks, along with a proposal for Priority Review. If the BLA has been completed and duly approved for review by the FDA, the FDA will set a target date for a determination under the Prescr...

Read More
news image

INDUSTRIAL IMPACT

OMEGA THERAPEUTICS ANNOUNCES STRATEGIC RESEARCH COLLABORATION WITH STANFORD UNIVERSITY SCHOOL OF MEDICINE

Omega Therapeutics, Inc | October 14, 2021

Omega Therapeutics, Inc. ("Omega"), a development-stage biotechnology company pioneering the first systematic approach to use mRNA therapeutics as programmable epigenetic medicines by leveraging its OMEGA Epigenomic Programing™ platform, today announced a strategic research collaboration with researchers at the Stanford University School of Medicine to explore the therapeutic potential of Omega Epigenomic Controllers (OECs) to control ocular disease genes associated with inflamma...

Read More
news image

RESEARCH

TURTLETREE LAUNCHES NEW RESEARCH AND DEVELOPMENT FACILITY IN GREATER SACRAMENTO

TurtleTree | October 04, 2021

TurtleTree has officially opened its new R&D facility in California's state capital. Located in West Sacramento, this 24,000-square-foot building will house a world-class research hub showcasing the company's extensive array of innovations and cell-based technologies. Representing a milestone in TurtleTree's US-based expansion plans, the research facility will spur the development of precision fermentation technology currently used to produce valuable milk in...

Read More
news image

BIOCLEAN INNOVATIONS AND REP-L® ANTIMICROBIALS PARTNERS TO LAUNCH A POWERFUL NON-TOXIC BIO-BASED ANTIMICROBIAL PRODUCT LINE

Bioclean Innovations | October 19, 2020

Bioclean Innovations Inc, a Biotech startup focused on innovative antimicrobial solutions to combat disease outbreaks has partnered with rep-L® Antimicrobials, to launch a powerful but non-toxic bio-based antimicrobial product line. Our rep-L-based disinfectants are designed to create a new methodology for addressing the infection control challenges facing the education and long-term health care sectors today. The SARS-CoV-2 virus responsible for the COVID-19 pandemic is one of an increasing...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us